By By Jackie Syrop | October 21, 2013
Higher levels of 25-hydroxyvitamin D are correlated with less multiple sclerosis (MS) disease activity and progression, according to a study presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2013 meeting in Copenhagen. Alberto Ascherio, MD, MPH, a professor of medicine at Brigham & Women’s Hospital and Harvard Medical School, presented data on 251 patients with 25-hydroxyvitamin D levels below 50 nanomoles per liter and 213 MS patients who had a higher level of 25-hydroxyvitamin D. Ascherio used the records of participants in the BENEFIT study, since the researchers from that trial collected data on baseline 25-hydroxyvitamin D for one year.
Continue Reading, Click Here
……..
To comment – click the comment link shown below
…….
USE OUR SHARE LINKS at the top of this page – to provide this
article to others
…….
USE OUR SHARE LINKS at the top of this page – to provide this
article to others
……
REMAIN up to date
with MS News and Education
with MS News and Education
Visit: www.msviewsandnews.org to register
…………………….
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews